← BackBrowse analysis archive →
Rosen Law Firm Urges ARS Pharmaceuticals (SPRY) Investors to Secure Counsel Ahead of Securities Class Action Deadline
Newsfile Corp · 76d ago · Sentiment -0.15
Read original ↗Impact scope
1 industry
direct 1
Top gainer
🔒
Top loser
🔒
Impact chainNews → industry → company, ranked top-down by impact
Pro only
Impact chains, crowding, market view and insider signals — try Pro free for 7 days when you sign up.
Start my free trial